nialamide has been researched along with Cerebral Palsy in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GADANO, JC | 1 |
| LAURO, EH | 1 |
| BASSA, DM | 1 |
2 other studies available for nialamide and Cerebral Palsy
| Article | Year |
|---|---|
[The use of nialamide in spastic children].
Topics: Cerebral Palsy; Child; Humans; Iproniazid; Muscle Spasticity; Nialamide | 1960 |
NIALAMIDE IN CHILDREN.
Topics: Adolescent; Cerebral Palsy; Child; Drug Therapy; Nialamide; Parent-Child Relations; Schizophrenia; S | 1964 |